Patient perspectives of prostate cancer screening vary by race following 2018 guideline changes.
BRFSS
cancer screening
health equity
prostate cancer
racial disparities
Journal
Cancer
ISSN: 1097-0142
Titre abrégé: Cancer
Pays: United States
ID NLM: 0374236
Informations de publication
Date de publication:
01 01 2023
01 01 2023
Historique:
revised:
23
08
2022
received:
01
07
2022
accepted:
16
09
2022
pubmed:
9
11
2022
medline:
15
12
2022
entrez:
8
11
2022
Statut:
ppublish
Résumé
The 2018 US Preventive Services Task Force guidelines recommend individualizing prostate cancer screening in 55- to 69-year-old men. Given the higher incidence of prostate cancer in African American (AA) compared to non-Hispanic White (NHW) men, this study compared reported rates of prostate-specific antigen (PSA) screening hypothesizing that it would not be commensurate with the relative risk between these two groups. Using the 2020 Behavioral Risk Factor Surveillance System, we identified 43,685 men (40,301 NHW and 3384 AA) interviewed about PSA screening. AA men had an odds ratio (OR) of 0.80 (95% confidence interval [CI], 0.69-0.93; p = .004) of reporting PSA screening; sequentially correcting for access to care, smoking, and age had minimal effect on this finding, but when correcting for income significantly attenuated this difference (OR, 0.95; 95% CI, 0.81-1.12). Further adding education level eliminated the effect size of AA race entirely with OR, 0.99 (95% CI, 0.84-1.17; p = .91). Further analysis found significant interaction between education and race, with college-educated AA men having 1.42 OR of receiving screening compared to college-educated NHW men. Despite prostate cancer being more common and having higher population-level mortality in AA than NHW men, PSA screening and education patterns do not reflect this increased risk even when adjusting for health access disparities. The authors' findings of significant effect from both income and education suggest that systemic racism is an important factor in the observed difference in PSA screening between AA men and NHW men. In the United States, prostate cancer is more common in African American men New guidelines from 2018 encourage physicians to consider risk factors in deciding whether or not to recommend screening, but overall African American men continue to be screened at a lower rate than non-Hispanic White men This effect disappears when correcting for income and education level, suggesting that several factors including systemic racism, medical mistrust, and self-advocacy may impact this observed difference.
Sections du résumé
BACKGROUND
The 2018 US Preventive Services Task Force guidelines recommend individualizing prostate cancer screening in 55- to 69-year-old men. Given the higher incidence of prostate cancer in African American (AA) compared to non-Hispanic White (NHW) men, this study compared reported rates of prostate-specific antigen (PSA) screening hypothesizing that it would not be commensurate with the relative risk between these two groups.
METHODS
Using the 2020 Behavioral Risk Factor Surveillance System, we identified 43,685 men (40,301 NHW and 3384 AA) interviewed about PSA screening.
RESULTS
AA men had an odds ratio (OR) of 0.80 (95% confidence interval [CI], 0.69-0.93; p = .004) of reporting PSA screening; sequentially correcting for access to care, smoking, and age had minimal effect on this finding, but when correcting for income significantly attenuated this difference (OR, 0.95; 95% CI, 0.81-1.12). Further adding education level eliminated the effect size of AA race entirely with OR, 0.99 (95% CI, 0.84-1.17; p = .91). Further analysis found significant interaction between education and race, with college-educated AA men having 1.42 OR of receiving screening compared to college-educated NHW men.
CONCLUSIONS
Despite prostate cancer being more common and having higher population-level mortality in AA than NHW men, PSA screening and education patterns do not reflect this increased risk even when adjusting for health access disparities. The authors' findings of significant effect from both income and education suggest that systemic racism is an important factor in the observed difference in PSA screening between AA men and NHW men.
LAY SUMMARY
In the United States, prostate cancer is more common in African American men New guidelines from 2018 encourage physicians to consider risk factors in deciding whether or not to recommend screening, but overall African American men continue to be screened at a lower rate than non-Hispanic White men This effect disappears when correcting for income and education level, suggesting that several factors including systemic racism, medical mistrust, and self-advocacy may impact this observed difference.
Substances chimiques
Prostate-Specific Antigen
EC 3.4.21.77
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
82-88Informations de copyright
© 2022 American Cancer Society.
Références
US Preventive Services Task Force. Screening for prostate cancer: US Preventive Services Task Force recommendation statement. JAMA. 2018;319(18):1901-1913. doi:10.1001/jama.2018.3710
American Cancer Society. Cancer Facts & Figures for African Americans 2016-2018; 2016. Accessed March 6, 2022. https://www.cancer.org/research/cancer-facts-statistics/cancer-facts-figures-for-african-americans.html
2020 Behavioral Risk Factor Surveillance System. Overview: BRFSS 2020. 2020. Accessed July 7, 2021. https://www.cdc.gov/brfss/annual_data/2020/pdf/overview-2020-508.pdf
Kim B. Hierarchical Linear Regression. 2016. Accessed May 20, 2016. https://data.library.virginia.edu/hierarchical-linear-regression/
R Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria; 2020.
Wickham H, Miller E. Import and Export ‘SPSS’. ‘STATA’ and ‘SAS’ Files; 2021. https://haven.tidyverse.org
Lumley T. Survey: analysis of complex survey samples. 2020. http://r-survey.r-forge.r-project.org/survey/
Cooper DL, Rollins L, Slocumb T, Rivers BM. Are men making informed decisions according to the prostate-specific antigen test guidelines? Analysis of the 2015 Behavioral Risk Factor Surveillance System. Am J Men's Health. 2019;13(2):1557988319834843. doi:10.1177/1557988319834843
Riviere P, Luterstein E, Kumar A, et al. Survival of African American and non-Hispanic White men with prostate cancer in an equal-access health care system. Cancer. 2020;126(8):1683-1690. doi:10.1002/cncr.32666
Barata P, Swami U, Kessel A, et al. Landscape of circulating tumor DNA (ctDNA) abnormalities in advanced prostate cancer (aPCa): Distinctions in African American (AA) versus Caucasian (Ca) patients. Paper presented at: American Society for Clinical Oncology - 2021 Genitourinary Cancers Symposium; 2021; February 11-13, 2021.
Leapman MS, Wang R, Park H, et al. Changes in prostate-specific antigen testing relative to the revised US Preventive Services Task Force recommendation on prostate cancer screening. JAMA Oncol. 2022;8(1):41-47. doi:10.1001/jamaoncol.2021.5143
Weise N, Shaya J, Javier-Desloges J, Cheng HH, Madlensky L, McKay RR. Disparities in germline testing among racial minorities with prostate cancer. Prostate Cancer Prostatic Dis. 2021;25(3):403-410. doi:10.1038/s41391-021-00469-3
Powell W, Richmond J, Mohottige D, Yen I, Joslyn A, Corbie-Smith G. Medical mistrust, racism, and delays in preventive health screening among African American men. Behav Med. 2019;45(2):102-117. doi:10.1080/08964289.2019.1585327
Allen JD, Porteny T, Kaplan A, Ladin K, Monahan K, Berry DL. Does shared decision-making for prostate cancer screening among African American men happen? It depends on who you ask. J Racial Ethn Health Disparities. 2021;9(4):1225-1233. doi:10.1007/s40615-021-01064-x
Adams LB, Richmond J, Corbie-Smith G, Powell W. Medical mistrust and colorectal cancer screening among African Americans. J Community Health. 2017;42(5):1044-1061. doi:10.1007/s10900-017-0339-2
Li J, Zhao G, Hall IJ. Pre-screening discussions and prostate-specific antigen testing for prostate cancer screening. Am J Prev Med. 2015;49(2):259-263. doi:10.1016/j.amepre.2015.02.007
United States Census Bureau. United States Census QuickFacts; 2022. Accessed March 6, 2022. https://www.census.gov/quickfacts/fact/table/US/PST045221